Cited by 141Cancer survivorship and careCancer, Stress, Anesthesia, and Immune ResponseCardiac Health and Mental Health

A randomized controlled trial of cognitive-behavioral stress management in breast cancer: survival and recurrence at 11-year follow-up

Open access
Stagl, Jamie M., Lechner, Suzanne C., Carver, Charles S., Bouchard, Laura C., Gudenkauf, Lisa M., Jutagir, Devika R., Diaz, Alain, Yu, Qilu +4 more·2015·Breast Cancer Research and Treatment

Abstract

Non-metastatic breast cancer patients often experience psychological distress which may influence disease progression and survival. Cognitive-behavioral stress management (CBSM) improves psychological adaptation and lowers distress during breast cancer treatment and long-term follow-ups. We examined whether breast cancer patients randomized to CBSM had improved survival and recurrence 8-15 years post-enrollment. From 1998 to 2005, women (N = 240) 2-10 weeks post-surgery for non-metastatic Stage 0-IIIb breast cancer were randomized to a 10-week, group-based CBSM intervention (n = 120) or a 1-day psychoeducational seminar control (n = 120). In 2013, 8-15 years post-study enrollment (11-year median), recurrence and survival data were collected. Cox Proportional Hazards Models and Weibull Accelerated Failure Time tests were used to assess group differences in all-cause mortality, breast cancer-specific mortality, and disease-free interval, controlling for biomedical confounders. Relative to the control, the CBSM group was found to have a reduced risk of all-cause mortality (HR = 0.21; 95 % CI [0.05, 0.93]; p = .040). Restricting analyses to women with invasive disease revealed significant effects of CBSM on breast cancer-related mortality (p = .006) and disease-free interval (p = .011). CBSM intervention delivered post-surgery may provide long-term clinical benefit for non-metastatic breast cancer patients in addition to previously established psychological benefits. Results should be interpreted with caution; however, the findings contribute to the limited evidence regarding physical benefits of psychosocial intervention post-surgery for non-metastatic breast cancer. Additional research is necessary to confirm these results and investigate potential explanatory mechanisms, including physiological pathways, health behaviors, and treatment adherence changes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10549-015-3626-6

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Randomized clinical trials of CBSM and Cancer Recovery have shown impressive impact of psychological treatment on quality of life in breast cancer survivors.

    “Randomized clinical trials of Cognitive Behavioral Stress Management (CBSM; Antoni) and Cancer Recovery (Anderson) have showed impressive impact of psychological treatment on depression and anxiety symptoms and quality of life in breast cancer survivors.”

    From Psychological Intervention and Breast Cancer (2024) · cites this paper as [12]

    The Introduction reports that women randomized to CBSM had fewer depressive symptoms and better emotional and physical well-being at follow-up; the Discussion also reports reduced anxiety and depressive mood and improved quality of life. The paper discusses Andersen’s intervention in relation to survival and recurrence, but does not establish the claimed psychological or quality-of-life effects for Cancer Recovery. Page numbers are not available in our copy. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Participation in a CBSM group during cancer treatment is associated with lower incidence of breast cancer mortality compared to patients provided only a brief, educational session during cancer treatment.

    “Stagl and Antoni’s group found that participation in a CBSM group during cancer treatment was associated with lower incidence of breast cancer mortality and greater disease-free interval than patients provided only a brief, educational session during cancer treatment [12].”

    From Psychological Intervention and Breast Cancer (2024) · cites this paper as [12]

    The Results (Effects in invasive cancer subsample; page unavailable) report lower breast cancer mortality and a greater disease-free interval for the CBSM group than for the psychoeducational control group. The citing sentence omits that these significant findings were restricted to women with invasive Stage I–IIIb disease; in the full sample, the corresponding results were only trends. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Participation in a CBSM group during cancer treatment is associated with greater disease-free interval compared to patients provided only a brief, educational session during cancer treatment.

    “Stagl and Antoni’s group found that participation in a CBSM group during cancer treatment was associated with lower incidence of breast cancer mortality and greater disease-free interval than patients provided only a brief, educational session during cancer treatment [12].”

    From Psychological Intervention and Breast Cancer (2024) · cites this paper as [12]

    The Results (Effects in invasive cancer subsample; page unavailable) report a greater disease-free interval for the CBSM group than for the control group, which received a one-day psychoeducational seminar. The citing sentence omits the restriction to women with invasive breast cancer: in the full sample, the Results describe only a tendency toward a greater disease-free interval (p = .083). (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Randomized clinical trials of CBSM and Cancer Recovery have shown impressive impact of psychological treatment on depression and anxiety symptoms in breast cancer survivors.

    “Randomized clinical trials of Cognitive Behavioral Stress Management (CBSM; Antoni) and Cancer Recovery (Anderson) have showed impressive impact of psychological treatment on depression and anxiety symptoms and quality of life in breast cancer survivors.”

    From Psychological Intervention and Breast Cancer (2024) · cites this paper as [12]

  • Women with Stage 0-IIIb breast cancer who were randomly assigned to a 10-week CBSM intervention, 2-10 weeks post-surgery, had longer survival up to 11-years post-enrollment compared to those in the control group, while accounting for disease relevant characteristics.

    “Their analysis found that women with Stage 0–IIIb breast cancer who were randomly assigned to a 10-week CBSM intervention, 2–10 weeks post-surgery, had longer survival, up to 11-years post-enrollment, compared to those in the control group, while accounting for disease relevant characteristics.”

    From Psychological Intervention and Breast Cancer (2024) · cites this paper as [12]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Stagl, J. M., Lechner, S. C., Carver, C. S., Bouchard, L. C., Gudenkauf, L. M., Jutagir, D. R., Diaz, A., Yu, Q., Blomberg, B. B., Ironson, G., Glück, S., & Antoni, M. H.
Affiliations
  • Massachusetts General Hospital (US)
  • University of Miami (US)
  • Westat (United States) (US)
  • Celgene (United States) (US)
Corresponding author
Stagl, Jamie M.
Venue
Breast Cancer Research and Treatment
Published
2015-10-30
Volume
154
Issue
2
Pages
319-328
ISSN
  • 0167-6806 (ISSN-L)
  • 1573-7217
OpenAlex
W1906194972
Cited by
141
References
31
Citations by year
2026: 11 · 2025: 15 · 2024: 16 · 2023: 11 · 2022: 14 · 2021: 14 · 2020: 22 · 2019: 14 · 2018: 9 · 2017: 9 · 2016: 6
FWCI
3.49
Type
journal article
Language
en
Open access
Locations
  • Breast Cancer Research and Treatment (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Cancer Institute (HHSN261200800001E, R01-CA-064710)
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Psychiatry and Mental health › Cancer, Stress, Anesthesia, and Immune Response
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords
cognitive-behavioral stress management, breast cancer, psychological distress, psychosocial interventions, breast cancer-specific mortality, all-cause mortality, disease-free interval, tumor recurrence, long-term follow-up, non-metastatic breast cancer
MeSH terms
Adaptation, Psychological, Adult, Breast Neoplasms, Cause of Death, Cognition, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Risk Factors, Stress, Psychological, Biomarkers, Tumor, Cognitive Behavioral Therapy, Proportional Hazards Models, Disease Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review